Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (15847)	2/25/1998 11:48:00 AM
From: Peter Singleton	Read Replies (1) \| Respond to of 32384

oops! I've just been reading along, 50 posts behind, responding to posts, and now that I've come to the end of the thread, I find that most of my comments had already been made by other folks. sorry for the thread clutter! hey, tonyt, forget about my private email a week ago or so suggesting you not post so much ... : ) Peter

To: Henry Niman who wrote (15847)	3/12/1998 2:30:00 AM
From: scaram(o)uche	Read Replies (4) \| Respond to of 32384

>>When LGND oscillates, the timers look like they know what they are doing (especially when they post after the fact)<< Since the post that you are responding to specifically mentioned me, I'll point out that I've called my sales clearly and in a timely fashion. This dates back to $17/share and misc.invest.stocks two years ago, when you and I were the two primary LGND proponents. >>but I still expect LGND to come close to the long term projections by analysts, which would put LGND's price around $50 in a few years and into triple digits shortly thereafter, which of course would be missed by short term timers<< Why would we miss it? When the day comes where Robinson is done diluting the heck out of his shareholders, it seems that we'll be the ones who are likely to recognize it and be on-board for the run. While I continue to respect (and appreciate) the job that you've done at keeping the on-line community informed of technical advances at the company, you've consistently missed one point that I and others have grasped..... Ligand's management has been shareholder-unfriendly. Your lack of respect for those with insight into the "let the shareholder take it on the chin" business plan gets old. Love Ligand. Love the science. When the time comes, I'll be there to ride along to success. Glad that you have provided the no-interest bridge financing. Your use of "of course" is not rational.